Navigation Links
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
Date:8/13/2009

which we have not previously addressed," Dr. Jiang, Chairman and CEO of Tianyin Pharmaceutical Co., Inc., commented. "We will produce both drugs in our new facility which just passed Sichuan provincial FDA inspection, a key component of GMP certification, in July. We believe the facility meets all GMP standards and we expect to receive certification in the very near term, a milestone which will significantly increase our capacity and enable us to achieve our growth objectives."

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 39 products, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 40 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 720 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 1,365 employees. Tianyin achieved revenue of approximately $33.5 million and net income of approximately $6 million in FY2008 ending June 30, 2008. For more information about Tianyin, please visit http://www.tianyinpharma.com .

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
2. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
4. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
5. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
6. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
7. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
8. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
9. Tianyin Pharmaceutical Appoints Three New Independent Board Members
10. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
11. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 IDEXX Laboratories, Inc. (NASDAQ: IDXX ... submitted over 100,000 specimens to IDEXX Reference Laboratories for ... 10 days since the breakthrough kidney function test launched ... leading cause of suffering and death in cats and ... with generally accepted kidney disease prevalence data showing that ...
(Date:7/24/2015)... 24, 2015 Ryan & Maniskas, LLP ... States District Court for the Northern District of ... that purchased the common stock of Avalanche Biotechnologies, Inc. ("Avalanche" ... 2014 and June 15, 2015, inclusive (the "Class Period"). ... move the Court for appointment as a lead plaintiff of ...
(Date:7/24/2015)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) will ... 2015 on Thursday, August 6 before the market opens. ... and discuss the financial results in a live webcast ... a.m. Pacific Time). The live call may ... or (847) 413-3238 (international), participant code 40327229. The webcast ...
(Date:7/24/2015)... , ... July 24, 2015 ... ... class-leading frozen sample management solution, indispensable to any modern scientific or pharmaceutical ... has a user-friendly interface. Users know precisely where a sample is located ...
Breaking Biology Technology:Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 2RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 4
... 2011 Oligomerix, Inc. presented results at the ... demonstrated that tau protein forms neurotoxic oligomers with ... results in tau,s self-fragmentation and in the degradation ... neurotoxic mode-of-action. Furthermore, certain tau oligomer species that ...
... RESTON, Virginia and BRNO, Czech Republic, November 16, ... Institute (MMCI) provides complete diagnostics, treatment, and ... and international patients. MMCI is the only health ... a member of the OECI (Organisation of European ...
... Livestream Info ... http://thehill.com/video/in-the-news/193083-livestreaming-genetic-testing-briefing . , Twitter: ... redefining cancer treatment, and the pace of discovery promises new ... That will be among the topics of discussion today at ...
Cached Biology Technology:A New Mechanism for Tau Protein Pathology in Alzheimer's Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting 2Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS 2Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS 3Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer 2
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
... people breathe while walking in the park, working in the ... spike their blood pressure, a new study suggests. Cardiovascular ... first to report a direct link between air pollution and ... results from these animal studies hold up, this could be ...
... time, next-generation DNA sequencing technologies have been turned on ... each year. The results will help to improve diagnosis, ... new strategies for vaccination. The study sets a ... a disease-causing bacterium: it is the first study of ...
... expectancy for patients with human immunodeficiency virus (HIV) has ... 1990s thanks to advancements in antiretroviral therapy, according to ... and Simon Fraser University in Vancouver, British Columbia. ... drop in AIDS deaths among 43,355 HIV-positive study participants ...
Cached Biology News:OSU study shows exposure to bad air raises blood pressure 2OSU study shows exposure to bad air raises blood pressure 3Defining DNA differences to track and tackle typhoid 2Defining DNA differences to track and tackle typhoid 3Anti-HIV therapy boosts life expectancy more than 13 years 2
BD BioCoat Collagen IV 150 mm Culture Dishes...
Gridded Cell Culture Petri Dish (20 mm molded in base), tissue-culture treated...
MAb to Desmoplakin I & II Desmoplakin I & II...
... PI is used in conjuction with ... in the earlier stages of apoptosis (Annexin ... are in later stages of apoptosis or ... PI is detected in the orange range ...
Biology Products: